Gerontology Center, Medical Centre Hospital of President's Affairs Administration of the Republic of Kazakhstan, Mangilik El 80, Astana City, 010000, Kazakhstan.
BMC Cardiovasc Disord. 2024 May 9;24(1):242. doi: 10.1186/s12872-024-03912-0.
Cardiac autonomic neuropathy (CAN) is a complication of diabetes mellitus (DM) that increases the risk of morbidity and mortality by disrupting cardiac innervation. Recent evidence suggests that CAN may manifest even before the onset of DM, with prediabetes and metabolic syndrome potentially serving as precursors. This study aims to identify genetic markers associated with CAN development in the Kazakh population by investigating the SNPs of specific genes.
A case-control study involved 82 patients with CAN (cases) and 100 patients without CAN (controls). A total of 182 individuals of Kazakh nationality were enrolled from a hospital affiliated with the RSE "Medical Center Hospital of the President's Affairs Administration of the Republic of Kazakhstan". 7 SNPs of genes FTO, PPARG, SNCA, XRCC1, FLACC1/CASP8 were studied. Statistical analysis was performed using Chi-square methods, calculation of odds ratios (OR) with 95% confidence intervals (CI), and logistic regression in SPSS 26.0.
Among the SNCA gene polymorphisms, rs2737029 was significantly associated with CAN, almost doubling the risk of CAN (OR 2.03(1.09-3.77), p = 0.03). However, no statistically significant association with CAN was detected with the rs2736990 of the SNCA gene (OR 1.00 CI (0.63-1.59), p = 0.99). rs12149832 of the FTO gene increased the risk of CAN threefold (OR 3.22(1.04-9.95), p = 0.04), while rs1801282 of the PPARG gene and rs13016963 of the FLACC1 gene increased the risk twofold (OR 2.56(1.19-5.49), p = 0.02) and (OR 2.34(1.00-5.46), p = 0.05) respectively. rs1108775 and rs1799782 of the XRCC1 gene were associated with reduced chances of developing CAN both before and after adjustment (OR 0.24, CI (0.09-0.68), p = 0.007, and OR 0.43, CI (0.22-0.84), p = 0.02, respectively).
The study suggests that rs2737029 (SNCA gene), rs12149832 (FTO gene), rs1801282 (PPARG gene), and rs13016963 (FLACC1 gene) may be predisposing factors for CAN development. Additionally, SNPs rs1108775 and rs1799782 (XRCC1 gene) may confer resistance to CAN. Only one polymorphism rs2736990 of the SNCA gene was not associated with CAN.
心脏自主神经病变(CAN)是糖尿病(DM)的一种并发症,它通过破坏心脏神经支配增加发病率和死亡率的风险。最近的证据表明,CAN 甚至可能在 DM 发病前就已经出现,前驱糖尿病和代谢综合征可能是其前兆。本研究旨在通过研究特定基因的 SNP,确定与哈萨克人群中 CAN 发展相关的遗传标记。
一项病例对照研究纳入了 82 例 CAN 患者(病例)和 100 例无 CAN 患者(对照)。从哈萨克斯坦共和国总统事务管理局医疗中心医院的一家附属医院共招募了 182 名哈萨克族个体。研究了 FTO、PPARG、SNCA、XRCC1、FLACC1/CASP8 基因的 7 个 SNP。使用卡方检验方法、95%置信区间(CI)计算比值比(OR)和 SPSS 26.0 中的 logistic 回归进行统计分析。
在 SNCA 基因多态性中,rs2737029 与 CAN 显著相关,使 CAN 的风险几乎增加了两倍(OR 2.03(1.09-3.77),p=0.03)。然而,SNCA 基因的 rs2736990 与 CAN 无统计学显著相关性(OR 1.00 CI(0.63-1.59),p=0.99)。FTO 基因的 rs12149832 使 CAN 的风险增加了三倍(OR 3.22(1.04-9.95),p=0.04),而 PPARG 基因的 rs1801282 和 FLACC1 基因的 rs13016963 使 CAN 的风险分别增加了两倍(OR 2.56(1.19-5.49),p=0.02)和(OR 2.34(1.00-5.46),p=0.05)。XRCC1 基因的 rs1108775 和 rs1799782 与发生 CAN 的几率降低相关,无论是在调整前还是调整后(OR 0.24,CI(0.09-0.68),p=0.007,和 OR 0.43,CI(0.22-0.84),p=0.02,分别)。
该研究表明,rs2737029(SNCA 基因)、rs12149832(FTO 基因)、rs1801282(PPARG 基因)和 rs13016963(FLACC1 基因)可能是 CAN 发展的易感因素。此外,SNP rs1108775 和 rs1799782(XRCC1 基因)可能赋予对 CAN 的抗性。只有一个 SNP rs2736990(SNCA 基因)与 CAN 无关。